Our research emphasizes four dimensions: 1) Innovation; 2) Communication; 3) Collaboration; 4) Translation.
Our core values are: 1) Integrity; 2) Circle of safety and trust; 3) Learning / openness to new ideas; 4) Effective work habits; 5) Creativity; 6) Teamwork; 7) Scientific excellence.
We pursue interdisciplinary research towards enhanced quantitative nuclear medicine (radiomolecular) imaging (PET & SPECT). Coupled with our provincial functional imaging and therapy program, we emphasize partnerships with other collaborators, clinical sites and industry, aiming to translate our image generation and analysis methods (including artificial intelligence) to state-of-the-art patient care and to impact quality of life. Our efforts include:
- Quantitative PET imaging methods for enhanced diagnosis, prognosis and treatment response assessment of cancer patients (e.g. prostate cancer, lymphoma, lung cancer, …)
- Quantitative SPECT-based dosimetry in molecular radiotherapy of cancer patients (also known as radionuclide, radioligand or radiopharmaceutical therapy)
- Radiomics and machine learning methods as applied to PET and SPECT imaging (cancer, cardiovascular disease and Parkinson’s disease)
- Dynamic whole-body PET/CT imaging
- Statistical image reconstruction algorithms
- Partial volume correction as applied to PET imaging of cancer as well as Alzheimer’s disease